Osteopontin promotes protective antigenic tolerance against experimental allergic airway disease

Journal of Immunology

Volumn 200, Issue 4, 2018, Pages 1270-1282

  Alissafi, Themis ^a,b   Kourepini, Evangelia ^a   Simoes, Davina C M ^a   Paschalidis, Nikolaos ^a   Aggelakopoulou, Maria ^a   Sparwasser, Tim ^c,d,e   Boon, Louis ^f   Hammad, Hamida ^b   Lambrecht, Bart N ^b   Panoutsakopoulou, Vily ^a  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b GHENT UNIVERSITY   (Belgium)

^c INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f BIOCEROS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BETA INTERFERON; INTERFERON RECEPTOR; OSTEOPONTIN; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR; SPP1 PROTEIN, MOUSE;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGENIC TOLERANCE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOLOGICAL TOLERANCE; MEDIASTINUM LYMPH NODE; MOUSE; MOUSE MODEL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; REGULATORY T LYMPHOCYTE; ANIMAL; DENDRITIC CELL; IMMUNOLOGY; RESPIRATORY TRACT ALLERGY; TRANSGENIC MOUSE;

ANIMALS; DENDRITIC CELLS; IMMUNE TOLERANCE; INTERFERON-BETA; MICE; MICE, TRANSGENIC; OSTEOPONTIN; RESPIRATORY HYPERSENSITIVITY; T-LYMPHOCYTES, REGULATORY;

EID: 85044776762     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1701345     Document Type: Article

References (62)

1. Lambrecht, B. N., and H. Hammad. 2015. The immunology of asthma. Nat. Immunol. 16: 45–56.
2. Lloyd, C. M., and C. M. Hawrylowicz. 2009. Regulatory T cells in asthma. Immunity 31: 438–449.
3. Palomares, O., M. Martín-Fontecha, R. Lauener, C. Traidl-Hoffmann, O. Cavkaytar, M. Akdis, and C. A. Akdis. 2014. Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-b. Genes Immun. 15: 511–520.
4. de Heer, H. J., H. Hammad, T. Soullié, D. Hijdra, N. Vos, M. A. Willart, H. C. Hoogsteden, and B. N. Lambrecht. 2004. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200: 89–98.
5. Xanthou, G., T. Alissafi, M. Semitekolou, D. C. Simoes, E. Economidou, M. Gaga, B. N. Lambrecht, C. M. Lloyd, and V. Panoutsakopoulou. 2007. Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat. Med. 13: 570–578.
6. Oriss, T. B., M. Ostroukhova, C. Seguin-Devaux, B. Dixon-McCarthy, D. B. Stolz, S. C. Watkins, B. Pillemer, P. Ray, and A. Ray. 2005. Dynamics of dendritic cell phenotype and interactions with CD4+ T cells in airway inflammation and tolerance. J. Immunol. 174: 854–863.
7. Akbari, O., and D. T. Umetsu. 2005. Role of regulatory dendritic cells in allergy and asthma. Curr. Allergy Asthma Rep. 5: 56–61.
8. Corry, D. B., and F. Kheradmand. 2005. The future of asthma therapy: integrating clinical and experimental studies. Immunol. Res. 33: 35–52.
9. Hawrylowicz, C. M., and A. O’Garra. 2005. Potential role of interleukin-10secreting regulatory T cells in allergy and asthma. Nat. Rev. Immunol. 5: 271–283.
10. O’Regan, A. W., G. J. Nau, G. L. Chupp, and J. S. Berman. 2000. Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. Immunol. Today 21: 475–478.
11. Chabas, D., S. E. Baranzini, D. Mitchell, C. C. Bernard, S. R. Rittling, D. T. Denhardt, R. A. Sobel, C. Lock, M. Karpuj, R. Pedotti, et al. 2001. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demy-elinating disease. Science 294: 1731–1735.
12. Wang, K. X., and D. T. Denhardt. 2008. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 19: 333–345.
13. Murugaiyan, G., A. Mittal, and H. L. Weiner. 2010. Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN-gamma limits IL-17-mediated autoimmune inflammation. Proc. Natl. Acad. Sci. USA 107: 11495–11500.
14. Shinohara, M. L., J. H. Kim, V. A. Garcia, and H. Cantor. 2008. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 29: 68–78.
15. Kourepini, E., N. Paschalidis, D. C. Simoes, M. Aggelakopoulou, J. L. Grogan, and V. Panoutsakopoulou. 2016. TIGIT enhances antigen-specific Th2 recall responses and allergic disease. J. Immunol. 196: 3570–3580.
16. Shinohara, M. L., L. Lu, J. Bu, M. B. Werneck, K. S. Kobayashi, L. H. Glimcher, and H. Cantor. 2006. Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat. Immunol. 7: 498–506.
17. Renkl, A. C., J. Wussler, T. Ahrens, K. Thoma, S. Kon, T. Uede, S. F. Martin, J. C. Simon, and J. M. Weiss. 2005. Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood 106: 946–955.
18. Kawamura, K., K. Iyonaga, H. Ichiyasu, J. Nagano, M. Suga, and Y. Sasaki. 2005. Differentiation, maturation, and survival of dendritic cells by osteopontin regulation. Clin. Diagn. Lab. Immunol. 12: 206–212.
19. Ashkar, S., G. F. Weber, V. Panoutsakopoulou, M. E. Sanchirico, M. Jansson, S. Zawaideh, S. R. Rittling, D. T. Denhardt, M. J. Glimcher, and H. Cantor. 2000. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287: 860–864.
20. Murugaiyan, G., A. Mittal, and H. L. Weiner. 2008. Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J. Immunol. 181: 7480–7488.
21. Uede, T. 2011. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathol. Int. 61: 265–280.
22. Gerstenfeld, L. C. 1999. Osteopontin in skeletal tissue homeostasis: an emerging picture of the autocrine/paracrine functions of the extracellular matrix. J. Bone Miner. Res. 14: 850–855.
23. Chiodoni, C., M. P. Colombo, and S. Sangaletti. 2010. Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis. Cancer Metastasis Rev. 29: 295–307.
24. Grassinger, J., D. N. Haylock, M. J. Storan, G. O. Haines, B. Williams, G. A. Whitty, A. R. Vinson, C. L. Be, S. Li, E. S. Sørensen, et al. 2009. Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins. Blood 114: 49–59.
25. Yamamoto, N., F. Sakai, S. Kon, J. Morimoto, C. Kimura, H. Yamazaki, I. Okazaki, N. Seki, T. Fujii, and T. Uede. 2003. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J. Clin. Invest. 112: 181–188.
26. Lund, S. A., C. M. Giachelli, and M. Scatena. 2009. The role of osteopontin in inflammatory processes. J. Cell Commun. Signal. 3: 311–322.
27. Weber, G. F., S. Ashkar, M. J. Glimcher, and H. Cantor. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271: 509–512.
28. Yokosaki, Y., N. Matsuura, T. Sasaki, I. Murakami, H. Schneider, S. Higashiyama, Y. Saitoh, M. Yamakido, Y. Taooka, and D. Sheppard. 1999. The integrin alpha(9)beta (1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. J. Biol. Chem. 274: 36328–36334.
29. Leavenworth, J. W., B. Verbinnen, J. Yin, H. Huang, and H. Cantor. 2015. A p85a-osteopontin axis couples the receptor ICOS to sustained Bcl-6 expression by follicular helper and regulatory T cells. Nat. Immunol. 16: 96–106.
30. Marson, A., K. Kretschmer, G. M. Frampton, E. S. Jacobsen, J. K. Polansky, K. D. MacIsaac, S. S. Levine, E. Fraenkel, H. von Boehmer, and R. A. Young. 2007. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445: 931–935.
31. Kourepini, E., M. Aggelakopoulou, T. Alissafi, N. Paschalidis, D. C. Simoes, and V. Panoutsakopoulou. 2014. Osteopontin expression by CD103- dendritic cells drives intestinal inflammation. Proc. Natl. Acad. Sci. USA 111: E856–E865.
32. van Rijt, L. S., S. Jung, A. Kleinjan, N. Vos, M. Willart, C. Duez, H. C. Hoogsteden, and B. N. Lambrecht. 2005. In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J. Exp. Med. 201: 981–991.
33. Asselin-Paturel, C., G. Brizard, J. J. Pin, F. Brière, and G. Trinchieri. 2003. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J. Immunol. 171: 6466–6477.
34. Swiecki, M., S. Gilfillan, W. Vermi, Y. Wang, and M. Colonna. 2010. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 33: 955–966.
35. McMillan, S. J., G. Xanthou, and C. M. Lloyd. 2005. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J. Immunol. 174: 5774–5780.
36. Semitekolou, M., T. Alissafi, M. Aggelakopoulou, E. Kourepini, H. H. Kariyawasam, A. B. Kay, D. S. Robinson, C. M. Lloyd, V. Panoutsakopoulou, and G. Xanthou. 2009. Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease. J. Exp. Med. 206: 1769–1785.
37. Naik, S. H., P. Sathe, H. Y. Park, D. Metcalf, A. I. Proietto, A. Dakic, S. Carotta, M. O’Keeffe, M. Bahlo, A. Papenfuss, et al. 2007. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat. Immunol. 8: 1217–1226.
38. Panoutsakopoulou, V., M. E. Sanchirico, K. M. Huster, M. Jansson, F. Granucci, D. J. Shim, K. W. Wucherpfennig, and H. Cantor. 2001. Analysis of the relationship between viral infection and autoimmune disease. Immunity 15: 137–147.
39. Humbles, A. A., C. M. Lloyd, S. J. McMillan, D. S. Friend, G. Xanthou, E. E. McKenna, S. Ghiran, N. P. Gerard, C. Yu, S. H. Orkin, and C. Gerard. 2004. A critical role for eosinophils in allergic airways remodeling. Science 305: 1776–1779.
40. Dahl, M. E., K. Dabbagh, D. Liggitt, S. Kim, and D. B. Lewis. 2004. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat. Immunol. 5: 337–343.
41. Hansen, G., G. Berry, R. H. DeKruyff, and D. T. Umetsu. 1999. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103: 175–183.
42. Krug, N., J. Madden, A. E. Redington, P. Lackie, R. Djukanovic, U. Schauer, S. T. Holgate, A. J. Frew, and P. H. Howarth. 1996. T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am. J. Respir. Cell Mol. Biol. 14: 319–326.
43. Osorio, F., C. Fuentes, M. N. López, F. Salazar-Onfray, and F. E. González. 2015. Role of dendritic cells in the induction of lymphocyte tolerance. Front. Immunol. 6: 535.
44. Maldonado, R. A., and U. H. von Andrian. 2010. How tolerogenic dendritic cells induce regulatory T cells. Adv. Immunol. 108: 111–165.
45. Wakkach, A., N. Fournier, V. Brun, J. P. Breittmayer, F. Cottrez, and H. Groux. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605–617.
46. Swiecki, M., and M. Colonna. 2010. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol. Rev. 234: 142–162.
47. Takagi, H., T. Fukaya, K. Eizumi, Y. Sato, K. Sato, A. Shibazaki, H. Otsuka, A. Hijikata, T. Watanabe, O. Ohara, et al. 2011. Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. Immunity 35: 958–971.
48. Förster, R., A. C. Davalos-Misslitz, and A. Rot. 2008. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8: 362–371.
49. Platt, A. M., and G. J. Randolph. 2013. Dendritic cell migration through the lymphatic vasculature to lymph nodes. Adv. Immunol. 120: 51–68.
50. Worbs, T., and R. Förster. 2007. A key role for CCR7 in establishing central and peripheral tolerance. Trends Immunol. 28: 274–280.
51. Weiner, H. L., A. P. da Cunha, F. Quintana, and H. Wu. 2011. Oral tolerance. Immunol. Rev. 241: 241–259.
52. Lahl, K., C. Loddenkemper, C. Drouin, J. Freyer, J. Arnason, G. Eberl, A. Hamann, H. Wagner, J. Huehn, and T. Sparwasser. 2007. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204: 57–63.
53. Holt, P. G., D. H. Strickland, M. E. Wikström, and F. L. Jahnsen. 2008. Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol. 8: 142–152.
54. Shevach, E. M. 2009. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636–645.
55. Albertsson, A. M., X. Zhang, J. Leavenworth, D. Bi, S. Nair, L. Qiao, H. Hagberg, C. Mallard, H. Cantor, and X. Wang. 2014. The effect of osteopontin and osteopontin-derived peptides on preterm brain injury. J. Neuro-inflammation 11: 197.
56. Doyle, K. P., T. Yang, N. S. Lessov, T. M. Ciesielski, S. L. Stevens, R. P. Simon, J. S. King, and M. P. Stenzel-Poore. 2008. Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke. J. Cereb. Blood Flow Metab. 28: 1235–1248.
57. Farkas, L., E. O. Kvale, F. E. Johansen, F. L. Jahnsen, and F. Lund-Johansen. 2004. Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides. J. Allergy Clin. Immunol. 114: 436–443.
58. Fonseca, D. E., and J. N. Kline. 2009. Use of CpG oligonucleotides in treatment of asthma and allergic disease. Adv. Drug Deliv. Rev. 61: 256–262.
59. Matsui, H., H. Tomizawa, K. Eiho, Y. Kashiwazaki, S. Edwards, M. Biffen, J. P. Bell, A. Bahl, A. J. Leishman, C. M. Murray, et al. 2012. Mechanism of action of inhibition of allergic immune responses by a novel antedrug TLR7 agonist. J. Immunol. 189: 5194–5205.
60. Metidji, A., S. A. Rieder, D. D. Glass, I. Cremer, G. A. Punkosdy, and E. M. Shevach. 2015. IFN-a/b receptor signaling promotes regulatory T cell development and function under stress conditions. J. Immunol. 194: 4265–4276.
61. Shields, J. D., I. C. Kourtis, A. A. Tomei, J. M. Roberts, and M. A. Swartz. 2010. Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 328: 749–752.
62. Shevde, L. A., S. Das, D. W. Clark, and R. S. Samant. 2010. Osteopontin: an effector and an effect of tumor metastasis. Curr. Mol. Med. 10: 71–81.